Investors

Press Releases

All Releases

View Summary Regeneron Announces Presentation at the 30th Annual J. P. Morgan Healthcare Conference
Jan 3, 2012
PDF 9.3 KB Add to Briefcase
View Summary Regeneron Announces Settlement of Patent Litigation with Genentech for U.S. Ophthalmic Sales of EYLEA™ (aflibercept) Injection
Jan 3, 2012
PDF 11.0 KB Add to Briefcase
View Summary Regeneron to Host Conference Call on January 3 at 8:30 a.m. Eastern Time to Discuss Ongoing Patent Litigation
Jan 2, 2012
PDF 9.6 KB Add to Briefcase
View Summary Two Year Results of Phase 3 Studies with EYLEA™ (aflibercept) Injection in wet AMD Show Sustained Improvement in Visual Acuity
Dec 5, 2011
PDF 20.4 KB Add to Briefcase
View Summary Regeneron Announces Presentation Time Change at the 2011 Deutsche Bank BioFEST
Dec 1, 2011
PDF 9.3 KB Add to Briefcase
View Summary Regeneron and Bayer Initiate Phase 3 Clinical Program for the Treatment of Wet Age-Related Macular Degeneration in China
Nov 28, 2011
PDF 18.7 KB Add to Briefcase
View Summary Regeneron Announces Upcoming Investor Conference Presentations
Nov 23, 2011
PDF 9.5 KB Add to Briefcase
View Summary Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review
Nov 22, 2011
PDF 19.1 KB Add to Briefcase
View Summary Rockefeller University President Marc Tessier-Lavigne Elected to Regeneron Board of Directors
Nov 21, 2011
PDF 12.6 KB Add to Briefcase
View Summary Regeneron Announces FDA Approval of EYLEA (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration: CORRECTED
Nov 18, 2011
PDF 22.5 KB Add to Briefcase
View Summary Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
Nov 10, 2011
PDF 21.2 KB Add to Briefcase
View Summary Regeneron Announces Presentation at the 2011 Credit Suisse Annual Healthcare Conference
Nov 7, 2011
PDF 9.3 KB Add to Briefcase
View Summary Positive Phase 2b Results with Sarilumab in Rheumatoid Arthritis to be Presented as a Late-Breaking Poster at the 2011 American College of Rheumatology Annual Meeting
Oct 27, 2011
PDF 14.6 KB Add to Briefcase
View Summary Regeneron Reports Third Quarter 2011 Financial and Operating Results
Oct 27, 2011
PDF 26.7 KB Add to Briefcase
View Summary Regeneron Pharmaceuticals Announces Pricing of Offering of Convertible Senior Notes due October 1, 2016
Oct 18, 2011
PDF 14.3 KB Add to Briefcase
View Summary Regeneron Pharmaceuticals Announces Proposed Offering of Convertible Senior Notes due 2016
Oct 17, 2011
PDF 13.8 KB Add to Briefcase
View Summary Regeneron Announces ZALTRAP® Clinical Presentation at European Multidisciplinary Cancer Congress
Sep 23, 2011
PDF 13.4 KB Add to Briefcase
View Summary Regeneron Ranked by Science Magazine as the #2 Employer in the Global Biopharmaceutical Industry
Sep 15, 2011
PDF 11.0 KB Add to Briefcase
View Summary Regeneron Announces Appointment of Joseph J. LaRosa as Senior Vice President, General Counsel and Secretary
Sep 6, 2011
PDF 10.1 KB Add to Briefcase
View Summary Regeneron Announces September 2011 Investor Conference Presentations
Aug 31, 2011
PDF 9.5 KB Add to Briefcase
Showing 101-120 of 215 Page: 1 2 3 4 5 6 7 8 9 10 11  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase


Close
Form content here please :)